Paper21391816
Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease.
Hart GW and 3 others. Annu Rev Biochem, 2011. Cited by 1,120 papers, by iCite.
Cite this record
ConductScience Library. Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease. Papers, record 21391816. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21391816
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acetylglucosamine | Major topic |
| Chronic Disease | Major topic |
| Signal Transduction | Major topic |
| Transcription, Genetic | Major topic |
| Animals | |
| Diabetes Mellitus | |
| Glycosylation | |
| Humans | |
| Models, Molecular | |
| Molecular Structure | |
| N-Acetylglucosaminyltransferases | |
| Neoplasms | |
| Neurodegenerative Diseases | |
| Phosphorylation | |
| Protein Conformation |
Source PubMed
Grants13
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 CA042486-28 | NCI NIH HHS | United States | R01CA042486 | PubMed and NIH | NIH RePORTER |
| R01 DK061671-10 | NIDDK NIH HHS | United States | R01DK061671 | PubMed and NIH | NIH RePORTER |
| R01 CA042486 | NCI NIH HHS | United States | R01CA042486 | PubMed and NIH | NIH RePORTER |
| R37 HD013563 | NICHD NIH HHS | United States | R37HD013563 | PubMed and NIH | NIH RePORTER |
| R33 DK071280-04 | NIDDK NIH HHS | United States | R33DK071280 | PubMed and NIH | NIH RePORTER |
| R33 DK071280 | NIDDK NIH HHS | United States | R33DK071280 | PubMed and NIH | NIH RePORTER |
| R01 DK061671 | NIDDK NIH HHS | United States | R01DK061671 | PubMed and NIH | NIH RePORTER |
| R37 HD013563-30 | NICHD NIH HHS | United States | R37HD013563 | PubMed and NIH | NIH RePORTER |
| R01 CA42486 | NCI NIH HHS | United States | R01CA042486 | PubMed and NIH | NIH RePORTER |
| R01 DK61671 | NIDDK NIH HHS | United States | R01DK061671 | PubMed and NIH | NIH RePORTER |
| P30 DK079637 | NIDDK NIH HHS | United States | P30DK079637 | PubMed and NIH | NIH RePORTER |
| R24 DK084949 | NIDDK NIH HHS | United States | R24DK084949 | PubMed and NIH | NIH RePORTER |
| R24 DK084949-01 | NIDDK NIH HHS | United States | R24DK084949 | PubMed and NIH | NIH RePORTER |
References227
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17507370 | Dynamic interplay between O-linked N-acetylglucosaminylation and glycogen synthase kinase-3-dependent phosphorylation. | Mol Cell Proteomics | 2007 | https://conductscience.org/library/papers/17507370 | PubMed |
| 2 | 18536723 | Structure of an O-GlcNAc transferase homolog provides insight into intracellular glycosylation. | Nat Struct Mol Biol | 2008 | https://conductscience.org/library/papers/18536723 | PubMed |
| 3 | 15249677 | O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease. | Proc Natl Acad Sci U S A | 2004 | https://conductscience.org/library/papers/15249677 | PubMed |
| 4 | 12724313 | Roles of the tetratricopeptide repeat domain in O-GlcNAc transferase targeting and protein substrate specificity. | J Biol Chem | 2003 | https://conductscience.org/library/papers/12724313 | PubMed |
| 5 | 20668475 | Aberrant O-GlcNAcylation characterizes chronic lymphocytic leukemia. | Leukemia | 2010 | https://conductscience.org/library/papers/20668475 | PubMed |
| 6 | 17122093 | Reduction of O-GlcNAc protein modification does not prevent insulin resistance in 3T3-L1 adipocytes. | Am J Physiol Endocrinol Metab | 2007 | https://conductscience.org/library/papers/17122093 | PubMed |
| 7 | 16244361 | Identification of the major site of O-linked beta-N-acetylglucosamine modification in the C terminus of insulin receptor substrate-1. | Mol Cell Proteomics | 2006 | https://conductscience.org/library/papers/16244361 | PubMed |
| 8 | 12471243 | The protein kinase complement of the human genome. | Science | 2002 | https://conductscience.org/library/papers/12471243 | PubMed |
| 9 | 12941958 | Diabetes and the accompanying hyperglycemia impairs cardiomyocyte calcium cycling through increased nuclear O-GlcNAcylation. | J Biol Chem | 2003 | https://conductscience.org/library/papers/12941958 | PubMed |
| 10 | 18587388 | A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo. | Nat Chem Biol | 2008 | https://conductscience.org/library/papers/18587388 | PubMed |
| 11 | 16339923 | Hexosamines, insulin resistance, and the complications of diabetes: current status. | Am J Physiol Endocrinol Metab | 2006 | https://conductscience.org/library/papers/16339923 | PubMed |
| 12 | 11148210 | Dynamic O-glycosylation of nuclear and cytosolic proteins: cloning and characterization of a neutral, cytosolic beta-N-acetylglucosaminidase from human brain. | J Biol Chem | 2001 | https://conductscience.org/library/papers/11148210 | PubMed |
| 13 | 19193796 | O-linked N-acetylglucosaminylation of Sp1 inhibits the human immunodeficiency virus type 1 promoter. | J Virol | 2009 | https://conductscience.org/library/papers/19193796 | PubMed |
| 14 | 2776765 | O-linked GlcNAc in serotype-2 adenovirus fibre. | Eur J Biochem | 1989 | https://conductscience.org/library/papers/2776765 | PubMed |
| 15 | 11150304 | Alternative O-glycosylation/O-phosphorylation of serine-16 in murine estrogen receptor beta: post-translational regulation of turnover and transactivation activity. | J Biol Chem | 2001 | https://conductscience.org/library/papers/11150304 | PubMed |
| 16 | 16970929 | Role of protein O-linked N-acetyl-glucosamine in mediating cell function and survival in the cardiovascular system. | Cardiovasc Res | 2007 | https://conductscience.org/library/papers/16970929 | PubMed |
| 17 | 18539296 | Non-canonical glycosyltransferase modulates post-hypoxic cardiac myocyte death and mitochondrial permeability transition. | J Mol Cell Cardiol | 2008 | https://conductscience.org/library/papers/18539296 | PubMed |
| 18 | 16964247 | Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability. | Nat Cell Biol | 2006 | https://conductscience.org/library/papers/16964247 | PubMed |
| 19 | 18664368 | A critical role of Sp1 transcription factor in regulating gene expression in response to insulin and other hormones. | Life Sci | 2008 | https://conductscience.org/library/papers/18664368 | PubMed |
| 20 | 2137449 | Enzymatic addition of O-GlcNAc to nuclear and cytoplasmic proteins. Identification of a uridine diphospho-N-acetylglucosamine:peptide beta-N-acetylglucosaminyltransferase. | J Biol Chem | 1990 | https://conductscience.org/library/papers/2137449 | PubMed |
Cited by781
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,120 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42875819 | Targeting Macrophage STING O-GlcNAcylation via Small-Molecule Allosteric Modulation for Psoriasis Therapy. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42875819 | PubMed |
| 42857445 | Tau protein in Parkinson's disease: advances in phosphoproteomics and molecular dynamics simulations. | Front Aging Neurosci | 2026 | https://conductscience.org/library/papers/42857445 | PubMed |
| 42750165 | TGFBI Maintains Fibrocartilage Homeostasis by Restraining O-GlcNAcylation to Inactivate and Destabilize ADAMTS16 in Temporomandibular Joint Osteoarthritis. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42750165 | PubMed |
| 42745977 | Antiproteinuric effect of dapagliflozin attenuates tubule-interstitial injury development in subclinical acute kidney injury animal model. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42745977 | PubMed |
| 42671010 | Multi-Technique Integration Identifies O-GlcNAc Transferase in Fibroblast-Like Synoviocytes as a Therapeutic Target for Rheumatoid Arthritis. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42671010 | PubMed |
| 42651138 | Brain O-GlcNAcylation in Neurodegenerative Diseases: Context-Dependent Mechanisms and Precision Therapeutic Translation. | Brain Sci | 2026 | https://conductscience.org/library/papers/42651138 | PubMed |
| 42622529 | Loss of O-GlcNAc transferase activity impairs the dynamic formation of protective stress granules in ischemic cardiomyocytes. | Biochem J | 2026 | https://conductscience.org/library/papers/42622529 | PubMed |
| 42589652 | Haptoglobin Phenotypes Stratify Post-Exertional Cognitive Dysfunction Associated with Altered Cerebral Oxygenation and Metabolic Signatures in Long COVID. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42589652 | PubMed |
| 42587000 | Hyper-O-GlcNAcylation destabilizes ARC to unleash NLRP3-mediated pyroptosis in diabetic cardiomyopathy. | Acta Pharmacol Sin | 2026 | https://conductscience.org/library/papers/42587000 | PubMed |
| 42533401 | Beyond Sequence: Posttranslational Remodeling of Antigens in Autoimmunity. | Immunol Rev | 2026 | https://conductscience.org/library/papers/42533401 | PubMed |
| 42469876 | Diabetic retinopathy: shaped by the "hidden hand" of post-translational modifications. | Mol Neurodegener | 2026 | https://conductscience.org/library/papers/42469876 | PubMed |
| 42387671 | Review of Congenital Myasthenic Syndrome Caused by Pathogenic Variants in GFPT1. | Muscle Nerve | 2026 | https://conductscience.org/library/papers/42387671 | PubMed |
| 42329389 | Paired tumor-normal metabolomic profiling reveals alterations in choline phospholipid precursor metabolism in biliary tract cancer. | J Gastroenterol | 2026 | https://conductscience.org/library/papers/42329389 | PubMed |
| 42326659 | Deciphering O‑GlcNAc-Dependent Signaling Via Integrated Proteomics and Phosphoproteomics. | ACS Omega | 2026 | https://conductscience.org/library/papers/42326659 | PubMed |
| 42192426 | Changes in cardiac myosin acetylation disrupt the super-relaxed state in genotype-negative hypertrophic cardiomyopathy with type 2 diabetes. | Cardiovasc Diabetol | 2026 | https://conductscience.org/library/papers/42192426 | PubMed |
| 42138072 | Disrupting VE-cadherin Y685 phosphorylation inhibits development of experimental diabetic and prediabetic retinopathy. | J Clin Invest | 2026 | https://conductscience.org/library/papers/42138072 | PubMed |
| 42135064 | SlSEC1- and SlSPY-mediated O-glycosylation stabilizes the transcription factor SlNOR to promote tomato fruit ripening. | Plant Cell | 2026 | https://conductscience.org/library/papers/42135064 | PubMed |
| 42097191 | Interplay between NRF2 post-translational modifications and protein-protein interactions: Perspectives from emerging structural and functional evidence. | Arch Biochem Biophys | 2026 | https://conductscience.org/library/papers/42097191 | PubMed |
| 42021865 | The oncogenic signalosome: SQSTM1/p62 as a master integrator of signaling, metabolism, and autophagy in cancer. | Toxicol Res | 2026 | https://conductscience.org/library/papers/42021865 | PubMed |
| 41939458 | Regulation of glycosylation in radiotherapy: exploring the multiple effects of DNA damage, immune response, stromal microenvironment and metabolism. | Front Oncol | 2026 | https://conductscience.org/library/papers/41939458 | PubMed |
Genes44
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21391816
GET https://conductscience.org/api/papers/v1/21391816/references?page=2